71 results
Page 3 of 4
424B4
9sq 1iqvxt5lchutj2
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
EX-1.1
wg4bltwn h7wia3
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
DRS
EX-1.1
pcswf a2wwez4ks60f
2 Jun 21
Draft registration statement
12:00am
DRS
0ixzn9r
2 Jun 21
Draft registration statement
12:00am
10-Q
6lfmy6u4jpaxo835s
17 May 21
Quarterly report
4:41pm
DEF 14A
64xuh4x nr9e3jn3
30 Apr 21
Definitive proxy
5:20pm
10-K
42vty7yh7fry7c774
31 Mar 21
Annual report
2:14pm
8-K
EX-3.1
a2hmj llzbp51r
29 Dec 20
Inhibikase Therapeutics, Inc. Announces Pricing of its Initial Public Offering
4:38pm
424B4
o8d couuxwff1wpeag
28 Dec 20
Prospectus supplement with pricing info
6:04am
S-1
EX-10.9
k9h vymlo0g
23 Jul 20
IPO registration
12:28pm
S-1
o5u75rr2fvce54sp
23 Jul 20
IPO registration
12:28pm